Renflexis

Renflexis (Infliximab-abda) is used to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, Crohn's disease, plaque psoriasis and ulcerative colitis. Renflexis is a biosimilar for remicade (infliximab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Renflexis may be covered by your Medicare or insurance plan.

With the Patient Assistance Program from Organon, receive your prescription at no charge if you are eligible.